2024-04-25  7:03:45 PM Chg. +1.43 Volume Bid7:03:46 PM Ask7:03:46 PM Market Capitalization Dividend Y. P/E Ratio
152.31USD +0.95% 1.9 mill.
Turnover: 172.62 mill.
152.26Bid Size: 200 152.32Ask Size: 200 69.49 bill.USD 1.03% 29.87

Business description

Zoetis (zô-EH-tis) is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 60 years of experience in animal health, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services. Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals with sales of its products in more than 100 countries.
 

Management board & Supervisory board

CEO
Kristin Peck
Management board
Wetteny Joseph, Nick Ashton, Jamie Brannan, Heidi Chen, Rimma Driscoll, Jeannette Ferran Astorga, Roxanne Lagano, Wafaa Mamilli, Robert Polzer
Supervisory board
Michael McCallister, Paul M. Bisaro, Vanessa Broadhurst, Frank D’Amelio, Sanjay Khosla, Antoinette R. Leatherberry, Gregory Norden, Louise M. Parent, Kristin Peck, Dr. Willie M. Reed, Dr. Linda Rhodes, Robert Scully
 

Company data

Name: Zoetis Inc.
Address: 10 Sylvan Way,Parsippany, New Jersey 07054, USA
Phone: +1-973-822-7000
Fax: -
E-mail: -
Internet: www.zoetis.com/
Industry: Healthcare
Sector: Pharmaceutical Industry
Sub sector: Pharmaceuticals
End of financial year: 12-31
Free Float: 83.54%
IPO date: 2013-02-01

Investor relations

Name: Steve Frank
IR phone: +1-973-822-7141
IR Fax: -
IR e-mail: steve.frank@zoetis.com

Company calendar

CW 18 | 2024-05-02 Interim Report 1st Quarter/3 Months
CW 23 | 2024-06-04 Dividend Payment